Low FT3 Levels Predict Risk for Nerve Damage in Diabetes
In euthyroid patients with type 2 diabetes (T2D), relatively higher free triiodothyronine (FT3) levels within the normal range were linked to a lower risk for diabetic peripheral neuropathy and better nerve function.
METHODOLOGY:
In euthyroid patients with T2D, lower FT3 levels within the normal range can worsen glucose and lipid metabolism and increase the risk for nephropathy and retinopathy, but the association of FT3 levels with peripheral neuropathy remains unclear.
Researchers in China examined the relationship between FT3 levels and diabetic peripheral neuropathy in 1422 euthyroid patients with T2D (mean age, 58.04 years; 33.97% women) who underwent electromyography during hospitalization.
Participants were considered euthyroid if their thyroid-stimulating hormone level was 0.25-5.5 IU/mL, free thyroxine level was 9.0-25.5 pmol/L, and FT3 level was 2.5-7.0 pmol/L.
A diagnosis of diabetic peripheral neuropathy was made in those who showed neuropathic symptoms (neuropathic pain, paresthesias, numbness, sensory distortion, unsteadiness, or falls) and signs (pain sensation abnormalities, vibration sensation abnormalities, loss of the ankle reflex, touch/pressure sensation abnormalities, or temperature sensation abnormalities) during or after confirmed diabetes diagnosis.
Nerve conduction studies of the distal limbs (median, ulnar, common peroneal, sural, and superficial peroneal nerves) were conducted in all participants, and distal motor and sensory nerve latencies, action potential amplitudes, and conduction velocities of motor and sensory nerves were recorded.
TAKEAWAY:
Among all participants with T2D, the 519 who were diagnosed with diabetic peripheral neuropathy showed significantly lower serum FT3 levels than those without the condition (P < .001).
The risk for diabetic peripheral neuropathy was reduced in participants with FT3 levels between 4.3 and 4.7 pmol/L (odds ratio [OR], 0.57; 95% CI, 0.39-0.81) and 4.7 and 7.0 pmol/L (OR, 0.33; 95% CI, 0.21-0.52) compared with those with FT3 levels between 2.5 and 3.8 pmol/L.
Participants with neuropathy had slower, weaker nerve responses and longer latencies than those without, with higher FT3 levels in patients with diabetic peripheral neuropathy being linked to faster nerve conduction and shorter latencies.
A Mendelian randomization analysis using the ThyroidOmics Consortium and the UK Biobank genome-wide association study data also indicated a causal relationship between low FT3 levels and the risk for diabetic peripheral neuropathy (inverse variance weighted β = -0.655; P = .035).
IN PRACTICE:
'Within the normal range, a relatively high level of FT3 (> 4.3 pmol/L) was associated with a reduced risk of DPN [diabetic peripheral neuropathy]. Thyroid hormones may be beneficial for patients with DPN if their FT3 levels are near the low end of the normal range,' the authors of the study wrote.
SOURCE:
This study was led by Bing'er Xu, Department of Endocrinology, Zhongshan Hospital, Fudan University, Shanghai, China. It was published online in the Journal of Clinical Endocrinology and Metabolism.
LIMITATIONS:
This study was limited by its single-center design and focused on hospitalized patients with T2D in Shanghai. It measured only specific peripheral nerves' conduction parameters. The Mendelian randomization analysis was conducted only in Europeans, requiring validation in other ethnic populations.
DISCLOSURES:
This study received support from the National Science and Technology Major Project, the National Natural Science Foundation of China, the Science and Technology Commission of Shanghai Municipality, and other sources. The authors reported having no conflicts of interest.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Phonon interference hits new heights, promising leaps in quantum and energy tech
Researchers at Rice University and their collaborators have achieved a groundbreaking demonstration of strong interference between phonons, the quantum units of vibrations that carry heat and sound within materials. Their discovery shows interference two orders of magnitude greater than any previously observed, opening new possibilities for quantum sensing and computing technologies. This phenomenon, known as Fano resonance, occurs when two phonons with different frequency distributions interfere with each other, producing distinctive patterns of amplification or cancellation—similar to overlapping ripples on a pond. 'While this phenomenon is well-studied for particles like electrons and photons, interference between phonons has been much less explored,' said Kunyan Zhang, a former postdoctoral researcher at Rice and first author on the study. 'That is a missed opportunity, since phonons can maintain their wave behavior for a long time, making them promising for stable, high-performance devices.' Phonons in quantum spotlight By proving phonons can be harnessed as effectively as electrons or light, this discovery opens the door to a new generation of phonon-based technologies. The researchers achieved their results by placing a two-dimensional (2D) metal layer atop a silicon carbide substrate using a method called confinement heteroepitaxy. They intercalated just a few layers of silver atoms between graphene and silicon carbide, creating a tightly bound interface with unique quantum properties. 'The 2D metal triggers and strengthens the interference between different vibrational modes in silicon carbide, reaching record levels,' Zhang explained. The team used Raman spectroscopy, a technique that measures vibrational modes, to study how phonons interfere. The resulting spectra displayed sharply asymmetric shapes and, in some cases, full dips forming antiresonance patterns, signatures of intense interference. The phenomenon was highly sensitive to the precise nature of the silicon carbide surface, with three different surface terminations each producing distinct Raman line shapes. Vibrational signals unlock secrets Remarkably, the presence of even a single dye molecule on the surface caused dramatic changes in the spectral line shape. 'This interference is so sensitive that it can detect the presence of a single molecule,' Zhang noted. 'It enables label-free single-molecule detection with a simple and scalable setup. Our results open up a new path for using phonons in quantum sensing and next-generation molecular detection.' The study also confirmed that the interference arises purely from phonon interactions rather than electrons, marking a rare example of phonon-only quantum interference. This effect appears only in the special 2D metal/silicon carbide system studied and does not exist in bulk metals due to unique transition pathways and surface configurations created by the atomically thin metal layer. Looking ahead, researchers are exploring other 2D metals, like gallium or indium, to replicate and customize this effect. 'Compared to conventional sensors, our method offers high sensitivity without the need for special chemical labels or complicated device setup,' said Shengxi Huang, associate professor at Rice and corresponding author on the study. 'This phonon-based approach not only advances molecular sensing but also opens up exciting possibilities in energy harvesting, thermal management and quantum technologies, where controlling vibrations is key.' Supported by the National Science Foundation, Air Force Office of Scientific Research, Welch Foundation, and University of North Texas, the study has been published in the journal Science Advances. Solve the daily Crossword
Medscape
5 hours ago
- Medscape
Growth Charts for Twins Improve Perinatal Risk Prediction
TOPLINE: New customised growth charts for twins (GROW-T), adjusted for maternal characteristics, more accurately predicted a small-for-gestational age (SGA)-associated risk for adverse perinatal outcomes than charts for singletons (GROW-S). METHODOLOGY: Researchers developed customised growth charts for twin pregnancies and compared them with singleton charts to evaluate their ability to identify SGA twins who are at an increased risk for adverse perinatal outcomes. They evaluated 8457 twin pregnancies (16,914 foetuses) from 127 NHS hospitals in the UK from January 2015 to February 2025, representing approximately two thirds of all NHS units. A mixed-effects linear regression analysis was performed to determine pregnancy-specific optimal weights at 37 weeks. Researchers compared GROW-T with GROW-S by calculating rates of the SGA-associated risk for stillbirth and adverse neonatal outcomes, such as the need for resuscitation, an Apgar score < 7 at 5 minutes, admission to the NICU, or neonatal death, using generalised estimating equations. TAKEAWAY: At 37 weeks, the average optimal weight of a twin was 389 g less than that of an equivalent singleton foetus. By pregnancy, 24.6% vs 64.9% of twins were classified as those with SGA (< 10th centile) according to GROW-T vs GROW-S; when analysed by individual foetuses, 13.8% vs 44.4% of twins were classified as those with SGA according to GROW-T vs GROW-S. Twins designated as SGA on the basis of GROW-T (odds ratio [OR], 7.2; 95% CI, 4.8-10.8) had a higher risk for stillbirth than those designated as SGA on the basis of GROW-S (OR, 2.8; 95% CI, 1.9-4.1). Twins classified as those with SGA on the basis of GROW-T had an increased need for resuscitation (OR, 1.3; 95% CI, 1.1-1.7), a lower Apgar score (< 7) at 5 minutes (OR, 1.8; 95% CI, 1.2-2.6), higher NICU admissions (OR, 1.3; 95% CI, 1.0-1.6), and an increased risk for neonatal death (OR, 5.4; 95% CI, 1.3-23.5). IN PRACTICE: "Our results add to the increasing evidence for adoption of twin specific charts," the authors wrote. "While adoption of twin specific charts is timely, implementation ought to be accompanied by evaluation in practice to monitor safety in different health service environments," they added. SOURCE: This study was led by Jason Gardosi, MD, Perinatal Institute, Birmingham, England, and was published online on August 01, 2025, in the American Journal of Obstetrics & Gynecology. LIMITATIONS: Ultrasound estimates of foetal weight in twins can be systematically overestimated, potentially affecting the accuracy of growth assessments. Chorionicity was not reported in the study cohort; however, the difference between growth curves of monochorionic and dichorionic twins was considered too small to be clinically relevant. DISCLOSURES: No funding information was provided for the study. All authors reported being employees of the Perinatal Institute, Birmingham, England. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Medscape
5 hours ago
- Medscape
Common Phthalate Tied to Coronary Risk in Car Plant Workers
TOPLINE: Exposure to monoethyl phthalate (MEP) — a chemical commonly found in industrial and personal care products — was associated with a substantially elevated risk for subclinical coronary atherosclerosis among men working in a car assembly unit. METHODOLOGY: Researchers conducted a cross-sectional study to assess whether urinary phthalates showed any association with subclinical coronary atherosclerosis. They included 1119 Spanish male workers (mean age, 50.9 years) from a car assembly plant. A total of 11 urinary phthalate metabolites were measured using liquid chromatography coupled to tandem mass spectrometry. Participants underwent CT scans between January 2011 and December 2014 to determine coronary artery calcium; subclinical coronary atherosclerosis was defined as a coronary artery calcium score ≥ 100 Agatston units. TAKEAWAY: Subclinical coronary atherosclerosis was identified in 114 men (10.2%). MEP was the phthalate with the highest median concentration; men with subclinical coronary atherosclerosis had a higher median MEP concentration than those without the condition (126.1 vs 99.3 µg/g creatinine). Each 1-unit increase in the natural logarithm of MEP was associated with a 21% higher prevalence of subclinical coronary atherosclerosis (adjusted odds ratio, 1.21; 95% CI, 1.02-1.44). Monoisobutyl phthalate and mono-n-butyl phthalate showed a positive association with the condition, but this association did not reach statistical significance. IN PRACTICE: "Educational strategies might complement cardiovascular prevention by promoting behaviors that reduce phthalate exposure, such as choosing fragrance-free products, preferring glass containers over plastics, and minimizing ultraprocessed food consumption," the researchers noted. SOURCE: This study was led by Diana María Mérida, Universidad Autónoma de Madrid, Madrid, Spain. It was published online on August 06, 2025, in The American Journal of Preventive Cardiology. LIMITATIONS: This cross-sectional study could not imply whether phthalates caused subclinical coronary atherosclerosis. The findings may not be generalisable to women, older adults, or individuals from different occupational backgrounds or socioeconomic groups. Urinary concentrations of phthalate metabolites reflect only short-term exposure, but chronic diseases are usually linked to long-term exposures. DISCLOSURES: This study was supported by the Health Research Fund from the State Secretary of R+D and FEDER/FSE, Instituto de Salud Carlos III, Spain. The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
